Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 2/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | PDE9A | O76083 | 1/20 | 0.31 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.31 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.31 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.30 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22156589 | 0.97 | PDE9A (0.33) | ADORA2AADORA1PDE9APDE1CSQOR | |
| SCHEMBL22157242 | 0.91 | SMN1; SMN2 (0.33) | ADORA2AADORA1SMN1; SMN2HIF1ACYP11B1 | |
| SCHEMBL22158542 | 0.91 | ADORA1 (0.33) | ADORA2AADORA1SMN1; SMN2HIF1ASQOR | |
| SCHEMBL22156588 | 0.90 | PDE9A (0.33) | ADORA2AADORA1SMN1; SMN2HIF1APDE9A | |
| SCHEMBL22157320 | 0.90 | SMN1; SMN2 (0.33) | ADORA2AADORA1SMN1; SMN2HIF1ACYP11B1 | |
| SCHEMBL22157335 | 0.89 | ADORA2A (0.33) | ADORA2AADORA1SQOR | |
| SCHEMBL22156665 | 0.89 | ADORA1 (0.36) | ADORA2AADORA1SMN1; SMN2HIF1ACYP11B1 | |
| SCHEMBL22157178 | 0.88 | SQOR (0.33) | ADORA2AADORA1SMN1; SMN2PDE9APDE1C | |
| SCHEMBL22158551 | 0.87 | NRP1 (0.32) | ADORA2AADORA1SMN1; SMN2HIF1ACYP11B1 | |
| SCHEMBL22155955 | 0.86 | SSTR2 (0.36) | ADORA2AADORA1SMN1; SMN2HIF1ACYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, OR51E2 | ADORA2A 4520/4885ADORA1 4534/4885SMN1; SMN2 4592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.